TG Therapeutics, Inc.TGTX announced an agreement with the FDA related to a Special Protocol Assessment (SPA) of the design of a phase III study (UNITY CLL) on TG 1101 (ublituximab) in combination with TGR 1202 (the combination referred to
Forex – financial instrument.Forex news
TG Therapeutics, Inc.TGTX announced an agreement with the FDA related to a Special Protocol Assessment (SPA) of the design of a phase III study (UNITY CLL) on TG 1101 (ublituximab) in combination with TGR 1202 (the combination referred to